Drawing based on the description in the official product monograph. No photo yet.
“20 mg / 12.5 mg: reddish-yellow, round, film-coated tablets; debossed with "OH1" on one side and plain on other side”
OH1 pill
Pill with imprint OH1 is red & yellow, round and has been identified as Olmesartan Medoxomil and Hydrochlorothiazide 20 mg / 12.5 mg. It is used for high blood pressure. It is supplied by Accord Healthcare Inc.
Sold in Canada
Olmesartan Medoxomil and Hydrochlorothiazide 20 mg / 12.5 mg
- Brand
- Ach-Olmesartan HCTZ
- Imprint
- OH1
- Strength
- Olmesartan Medoxomil 20 mg / Hydrochlorothiazide 12.5 mg
- Used for
- High blood pressure
- Color
- Red, Yellow
- Shape
- Round
- Form
- Tablet
- Manufacturer
- Accord Healthcare Inc
- Drug class
- ARB (blood pressure medicine)
- Sold in
- Canada
- DIN
- 02468948
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
All Olmesartan Medoxomil and Hydrochlorothiazide pills and guides
What is Olmesartan Medoxomil and Hydrochlorothiazide used for?
Olmesartan Medoxomil and Hydrochlorothiazide is used for high blood pressure.
- Medicine type
- ARB (blood pressure medicine); thiazide diuretic (water pill)
Official uses from the US prescribing label
Olmesartan medoxomil and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (CV) events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil and hydrochlorothiazide tablets.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Olmesartan medoxomil and hydrochlorothiazide tablets may be used alone, or in combination with other antihypertensive drugs.
Limitations of Use Olmesartan medoxomil and hydrochlorothiazide tablets is not indicated for the initial therapy of hypertension.
From the FDA-approved label on DailyMed (published Oct 01, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows OH1.
- It is red & yellow, round.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Ach-Olmesartan HCTZ by Accord Healthcare Inc.
In Canada: prescription only.
Ingredients
Active: Olmesartan Medoxomil, Hydrochlorothiazide
Other pills with imprint OH1
Same imprint, different listing. Check the color, size and maker against your pill.
- OH1 Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 20 mg Red & yellow, round Used for high blood pressure
- OH1 Olmesartan Medoxomil and Hydrochlorothiazide 20 mg / 12.5 mg Yellow, round, 9 mm Used for high blood pressure
- OH1 Olmesartan Medoxomil and Hydrochlorothiazide 20 mg / 12.5 mg Red & yellow, round Used for high blood pressure
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AA 14
Desipramine 75 mg
Red, round, 10 mm
Used for depression and ADHD
-
EE
Enalapril Maleate 10 mg
Red, round, 9 mm
Used for severe high blood pressure and heart failure
-
WL170
Sodium Fluoride 0.5 mg / 750 mcg / 24 mg / 36 mg / 10 mcg / 6.75 mg / 1.05 mg / 1.2 mg / 13.5 mg / 1.05 mg / 500 mcg / 4.5 mcg
Red, round, 13 mm
-
AN 55
Demeclocycline 300 mg
Red, round, 20 mm
Used for urinary tract infections (UTIs) and gonorrhea
-
AN 54
Demeclocycline 150 mg
Red, round, 9 mm
Used for urinary tract infections (UTIs) and gonorrhea
-
DJ
Estradiol Valerate/Dienogest 2 mg / 2 mg
Red, round, 6 mm
Other Olmesartan Medoxomil and Hydrochlorothiazide pills
- OLH Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg / 20 mg Orange, round, 8 mm Used for high blood pressure
- C22 Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 20 mg Red & yellow, round, 8.5 mm Used for high blood pressure
- OH 41 Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 40 mg Orange, oval Used for high blood pressure
- 439 Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 40 mg Orange, oval Used for high blood pressure
- OH2 Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 40 mg Red & yellow, oval Used for high blood pressure
- Sankyo C22 Olmesartan Medoxomil and Hydrochlorothiazide 20 mg / 12.5 mg Yellow, round, 9 mm Used for high blood pressure
- 346 L Olmesartan Medoxomil and Hydrochlorothiazide 20 mg / 12.5 mg Yellow, round, 9 mm Used for high blood pressure